Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff.
Detact Diagnostics has raised $5.9M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Detact Diagnostics's investors include Bill & Melinda Gates Foundation, NV NOM, Pacific 6 Enterprises, JM Molina Investments.
Detact Diagnostics is headquartered in Delfzijl, The Netherlands.
Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff.
Detact Diagnostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Detact Diagnostics — Funding & Investors." VCBacked, November 7, 2025, https://www.vcbacked.co/company/detact-diagnostics. Accessed September 30, 2026.
VCBacked. (2025). Detact Diagnostics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/detact-diagnostics
{{cite web |title=Detact Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/detact-diagnostics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated